Lv4
418 积分 2025-07-05 加入
Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
18天前
已完结
Composite renal outcome in prospectively performed biopsy proven diabetic kidney disease versus non-diabetic kidney disease: A longitudinal follow up
24天前
已关闭
Comparative Analysis of Lupus Nephritis Guidelines: ACR 2025, EULAR 2025, and KDIGO 2024
27天前
已完结
What’s New in Membranous Nephropathy and How to Incorporate New Antigen Discoveries Into Clinical Practice: A Review
27天前
已完结
Dual-antigen membranous nephropathy
27天前
已完结
Systemic lupus erythematosus
1个月前
已完结
Efficacy and safety of finerenone with SGLT2i in IgA nephropathy
1个月前
已完结
Efficacy and safety of finerenone in non-diabetic patients with IgA nephropathy
1个月前
已完结
Streamlining the Histopathological Workflow in Diabetic Kidney Disease with Artificial Intelligence
1个月前
已完结
The updated global burden of chronic kidney disease: one death every 20 seconds
1个月前
已完结
皖公网安备34019202002308
